Prevnar 20 2.2 ug/.5mL
Pneumococcal 20-valent Conjugate Vaccine · INJECTION, SUSPENSION · Wyeth Pharmaceutical Division of Wyeth Holdings LLC
Prevnar 20 is a injection, suspension containing pneumococcal 20-valent conjugate vaccine at 2.2 ug/.5mL, taken intramuscular. Manufactured by Wyeth Pharmaceutical Division of Wyeth Holdings LLC.
Key Facts
- Brand Name
- Prevnar 20
- Generic Name
- Pneumococcal 20-valent Conjugate Vaccine
- NDC Code (Product)
0005-2000- Manufacturer
- Wyeth Pharmaceutical Division of Wyeth Holdings LLC
- Strength
- 2.2 ug/.5mL
- Dosage Form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA125731
- Marketing Start
- 08/10/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is Prevnar 20 used for?
Prevnar 20 contains Pneumococcal 20-valent Conjugate Vaccine. It is a injection, suspension taken intramuscular. Consult your doctor for specific uses.
Is Prevnar 20 a controlled substance?
Prevnar 20 is not classified as a controlled substance by the DEA.
What is the generic name for Prevnar 20?
The generic name for Prevnar 20 is Pneumococcal 20-valent Conjugate Vaccine. There are 1 other brand versions of Pneumococcal 20-valent Conjugate Vaccine.
What is the NDC code for Prevnar 20 2.2 ug/.5mL?
The NDC (National Drug Code) for Prevnar 20 2.2 ug/.5mL is 0005-2000, listed by Wyeth Pharmaceutical Division of Wyeth Holdings LLC.